• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种人源 IgG1-Fc 变体可增强 ADCC。

A variant human IgG1-Fc mediates improved ADCC.

机构信息

MedImmune, Granta Park, Cambridge, UK.

出版信息

Protein Eng Des Sel. 2011 Sep;24(9):671-8. doi: 10.1093/protein/gzr015. Epub 2011 May 18.

DOI:10.1093/protein/gzr015
PMID:21596686
Abstract

Ribosome display was applied to the Fc region of human immunoglobulin G (IgG1) to select for improved binding to human FcγRIIIa, the receptor expressed on human natural killer cells that mediates antibody-dependent cellular cytotoxicity (ADCC). A library of human Fcγ1 variants was generated using error-prone polymerase chain reaction, and subjected to multiple rounds of ribosome display selection against progressively decreasing concentrations of soluble human FcγRIIIa, to enrich for improved binders. Radioimmunoassay and alphascreen analyses of the aglycosylated IgG-Fc output revealed variants with improved binding to FcγRIIIa relative to wild-type IgG-Fc. Subsequent expression in human (HEK-EBNA) cells generated glycosylated IgGs with modified activity in ADCC assays. One particular variant, 125_B01 triggered enhanced ADCC (EC(50) up to four-fold reduced with increased maximal lysis) relative to wild-type antibody, having more equal levels of ADCC for each allotype (V158/F158) of FcγRIIIa. Deconvolution of individual replacements within the variant showed that improved function arose from the Phe243Leu replacement within the CH2 domain, rather than the CH3 domain replacements Thr393Ala or His433Pro. Surprisingly, the oligosaccharide profiles of 125_B01 indicated more oligosaccharide chains lacking fucose, or with bisecting N-acetylglucosamine relative to wild-type IgG1, which correlates with improved function and the replacement Phe243Leu that is a carbohydrate contact residue within the C(H)2 domain.

摘要

核糖体展示技术被应用于人免疫球蛋白 G(IgG1)的 Fc 区域,以筛选对人 FcγRIIIa 具有更好结合力的变体,FcγRIIIa 是表达于自然杀伤细胞表面的受体,介导抗体依赖的细胞毒性(ADCC)。使用易错聚合酶链反应生成了人 Fcγ1 变体文库,并对其进行了多轮核糖体展示筛选,以降低可溶性人 FcγRIIIa 的浓度,从而富集具有更好结合力的变体。未经糖基化的 IgG-Fc 的放射免疫分析和 alphascreen 分析显示,与野生型 IgG-Fc 相比,变体与 FcγRIIIa 的结合得到了改善。随后在人(HEK-EBNA)细胞中表达,产生了具有修饰的 ADCC 活性的糖基化 IgG。特别是变体 125_B01 与野生型抗体相比,触发了增强的 ADCC(EC50 降低了四倍,最大裂解增加),对于 FcγRIIIa 的每种同种型(V158/F158),ADCC 水平更加均等。对变体中单个替换的剖析表明,功能的改善源于 CH2 结构域中的 Phe243Leu 替换,而不是 CH3 结构域中的 Thr393Ala 或 His433Pro 替换。令人惊讶的是,125_B01 的寡糖图谱表明,更多的寡糖链缺乏岩藻糖,或者具有双分支 N-乙酰葡萄糖胺,与野生型 IgG1 相比,这与功能的改善以及与 Phe243Leu 替换相关,该替换是 CH(H)2 结构域中的一个碳水化合物接触残基。

相似文献

1
A variant human IgG1-Fc mediates improved ADCC.一种人源 IgG1-Fc 变体可增强 ADCC。
Protein Eng Des Sel. 2011 Sep;24(9):671-8. doi: 10.1093/protein/gzr015. Epub 2011 May 18.
2
Comparison of biological activity among nonfucosylated therapeutic IgG1 antibodies with three different N-linked Fc oligosaccharides: the high-mannose, hybrid, and complex types.具有三种不同N-连接Fc寡糖(高甘露糖型、杂合型和复合型)的非岩藻糖基化治疗性IgG1抗体之间的生物学活性比较。
Glycobiology. 2007 Jan;17(1):104-18. doi: 10.1093/glycob/cwl057. Epub 2006 Sep 29.
3
Combined Fc-protein- and Fc-glyco-engineering of scFv-Fc fusion proteins synergistically enhances CD16a binding but does not further enhance NK-cell mediated ADCC.Fc 蛋白和 Fc 糖基工程联合修饰 scFv-Fc 融合蛋白可协同增强 CD16a 结合,但不能进一步增强 NK 细胞介导的 ADCC。
J Immunol Methods. 2011 Oct 28;373(1-2):67-78. doi: 10.1016/j.jim.2011.08.003. Epub 2011 Aug 9.
4
Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa.人IgG1寡糖中的岩藻糖缺失增强了IgG1与FcγRIIIa之间的结合焓和缔合速率。
J Mol Biol. 2004 Mar 5;336(5):1239-49. doi: 10.1016/j.jmb.2004.01.007.
5
Importance of the Side Chain at Position 296 of Antibody Fc in Interactions with FcγRIIIa and Other Fcγ Receptors.抗体Fc第296位侧链在与FcγRIIIa及其他Fcγ受体相互作用中的重要性
PLoS One. 2015 Oct 7;10(10):e0140120. doi: 10.1371/journal.pone.0140120. eCollection 2015.
6
Fucose removal from complex-type oligosaccharide enhances the antibody-dependent cellular cytotoxicity of single-gene-encoded antibody comprising a single-chain antibody linked the antibody constant region.从复合型寡糖中去除岩藻糖可增强单基因编码抗体的抗体依赖性细胞毒性,该单基因编码抗体由连接抗体恒定区的单链抗体组成。
J Immunol Methods. 2005 Nov 30;306(1-2):93-103. doi: 10.1016/j.jim.2005.07.025. Epub 2005 Oct 3.
7
Correlation between CD16a binding and immuno effector functionality of an antigen specific immunoglobulin Fc fragment (Fcab).抗原特异性免疫球蛋白 Fc 片段(Fcab)的 CD16a 结合与免疫效应功能之间的相关性。
Arch Biochem Biophys. 2012 Oct 15;526(2):154-8. doi: 10.1016/j.abb.2012.05.010. Epub 2012 May 23.
8
Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.低岩藻糖基化IgG1抗体依赖性细胞毒性的增强与FcγRIIIa功能多态性无关。
Clin Cancer Res. 2004 Sep 15;10(18 Pt 1):6248-55. doi: 10.1158/1078-0432.CCR-04-0850.
9
Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.低岩藻糖基化IgG1抗体增强自然杀伤细胞的结合与激活,可在较低抗原密度下有效诱导抗体依赖性细胞毒性。
Clin Cancer Res. 2005 Mar 15;11(6):2327-36. doi: 10.1158/1078-0432.CCR-04-2263.
10
Expression of GnTIII in a recombinant anti-CD20 CHO production cell line: Expression of antibodies with altered glycoforms leads to an increase in ADCC through higher affinity for FC gamma RIII.GnTIII在重组抗CD20 CHO生产细胞系中的表达:具有改变糖型的抗体的表达通过对FcγRIII的更高亲和力导致ADCC增加。
Biotechnol Bioeng. 2001 Aug 20;74(4):288-94.

引用本文的文献

1
Systematic analysis of Fc mutations designed to enhance binding to Fc-gamma receptors.系统分析设计用于增强与 Fcγ 受体结合的 Fc 突变。
MAbs. 2024 Jan-Dec;16(1):2406539. doi: 10.1080/19420862.2024.2406539. Epub 2024 Sep 22.
2
Optimized Production of Fc Fusion Proteins by Sortase Enzymatic Ligation.通过分选酶酶促连接优化Fc融合蛋白的生产。
Ind Eng Chem Res. 2021 Dec 1;60(47):16839-16853. doi: 10.1021/acs.iecr.1c02842. Epub 2021 Nov 18.
3
Quantification of protein cargo loading into engineered extracellular vesicles at single-vesicle and single-molecule resolution.
以单囊泡和单分子分辨率定量工程细胞外囊泡中的蛋白质货物装载。
J Extracell Vesicles. 2021 Aug;10(10):e12130. doi: 10.1002/jev2.12130. Epub 2021 Aug 2.
4
Optimization of therapeutic antibodies.治疗性抗体的优化
Antib Ther. 2021 Feb 18;4(1):45-54. doi: 10.1093/abt/tbab003. eCollection 2021 Jan.
5
Loop Grafting between Similar Local Environments for Fc-Silent Antibodies.Fc沉默抗体在相似局部环境之间的环嫁接
J Chem Inf Model. 2020 Nov 23;60(11):5475-5486. doi: 10.1021/acs.jcim.9b01198. Epub 2020 May 19.
6
Antigen-Induced Allosteric Changes in a Human IgG1 Fc Increase Low-Affinity Fcγ Receptor Binding.抗原诱导的人 IgG1 Fc 变构改变增加了低亲和力 Fcγ 受体结合。
Structure. 2020 May 5;28(5):516-527.e5. doi: 10.1016/j.str.2020.03.001. Epub 2020 Mar 24.
7
Structure and biophysical characterization of the human full-length neurturin-GFRa2 complex: A role for heparan sulfate in signaling.人全长神经胶质细胞源性神经营养因子-GFRa2 复合物的结构与生物物理特征:硫酸乙酰肝素在信号转导中的作用。
J Biol Chem. 2018 Apr 13;293(15):5492-5508. doi: 10.1074/jbc.RA117.000820. Epub 2018 Feb 2.
8
The interleukin-like epithelial-mesenchymal transition inducer ILEI exhibits a non-interleukin-like fold and is active as a domain-swapped dimer.白细胞介素样上皮-间质转化诱导因子ILEI呈现出非白细胞介素样的折叠结构,并且作为结构域交换二聚体具有活性。
J Biol Chem. 2017 Sep 15;292(37):15501-15511. doi: 10.1074/jbc.M117.782904. Epub 2017 Jul 27.
9
Advances in Therapeutic Fc Engineering - Modulation of IgG-Associated Effector Functions and Serum Half-life.治疗性Fc工程进展——IgG相关效应功能及血清半衰期的调控
Front Immunol. 2016 Dec 12;7:580. doi: 10.3389/fimmu.2016.00580. eCollection 2016.
10
A perspective on the structure and receptor binding properties of immunoglobulin G Fc.关于免疫球蛋白G Fc的结构和受体结合特性的观点
Biochemistry. 2015 May 19;54(19):2931-42. doi: 10.1021/acs.biochem.5b00299. Epub 2015 May 7.